SauCas9-based cell cycle-dependent genome editing via AAV delivery
Molecular Therapy Advances · 2026-06 · 34 (2) · 201751
DOI: 10.1016/j.omta.2026.201751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-06. Verfasst von Erina Matsugi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JST, Japan Society for the Promotion of Science, Takeda Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.
- School of Pharmaceutical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.
Förderung
- JST
- Japan Society for the Promotion of Science
- Takeda Science Foundation
- The Uehara Memorial Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Naito Foundation
- Suzuken Memorial Foundation
Zitieren
APA
Matsugi, E., Kishi, K., Kishi, A., Nagase, K., Nigorikawa, K., & Nomura, W. (2026). SauCas9-based cell cycle-dependent genome editing via AAV delivery. Molecular Therapy Advances, 34(2), 201751. https://doi.org/10.1016/j.omta.2026.201751
Vancouver
Matsugi E, Kishi K, Kishi A, Nagase K, Nigorikawa K, Nomura W. SauCas9-based cell cycle-dependent genome editing via AAV delivery. Molecular Therapy Advances. 2026;34(2):201751. doi:10.1016/j.omta.2026.201751
BibTeX
@article{Matsugi2026,
author = {Matsugi, Erina and Kishi, Kanae and Kishi, Ayane and Nagase, Kohei and Nigorikawa, Kiyomi and Nomura, Wataru},
title = {SauCas9-based cell cycle-dependent genome editing via AAV delivery},
journal = {Molecular Therapy Advances},
year = {2026},
volume = {34},
number = {2},
pages = {201751},
doi = {10.1016/j.omta.2026.201751}
}
EUVIMED